ImportRefusal LogoImportRefusal

Legaay International

⚠️ Moderate Risk

FEI: 3004723151 • Rotterdam, Zuid-Holland • NETHERLANDS

FEI

FEI Number

3004723151

📍

Location

Rotterdam, Zuid-Holland

🇳🇱
🏢

Address

Van Helmontstraat 99, , Rotterdam, Zuid-Holland, Netherlands

Moderate Risk

FDA Import Risk Assessment

42.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

23
Total Refusals
4
Unique Violations
5/20/2014
Latest Refusal
8/30/2005
Earliest Refusal

Score Breakdown

Violation Severity
61.4×40%
Refusal Volume
51.1×30%
Recency
0.0×20%
Frequency
26.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

11821×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

7514×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3417×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

712×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

Refusal History

DateProductViolationsDivision
5/20/2014
57IH17MEASLES, MUMPS, RUBELLA VIRUS VACCINE
71NO LICENSE
Los Angeles District Office (LOS-DO)
3/3/2014
57CH21YELLOW FEVER VACCINE
71NO LICENSE
Los Angeles District Office (LOS-DO)
5/11/2006
80FMFSYRINGE, PISTON
118NOT LISTED
341REGISTERED
New York District Office (NYK-DO)
5/11/2006
79KGXTAPE AND BANDAGE, ADHESIVE
118NOT LISTED
341REGISTERED
New York District Office (NYK-DO)
5/11/2006
86HOYSHIELD, EYE, OPHTHALMIC (INCLUDING SUNLAMP PROTECTIVE EYEWEAR AND POST-MYDRIATIC EYEWEAR)
118NOT LISTED
341REGISTERED
New York District Office (NYK-DO)
5/11/2006
80FMQRESTRAINT, PROTECTIVE
118NOT LISTED
341REGISTERED
New York District Office (NYK-DO)
5/11/2006
89ITGBANDAGE, CAST
118NOT LISTED
341REGISTERED
New York District Office (NYK-DO)
5/11/2006
79GEMGAUZE, ABSORBABLE
118NOT LISTED
341REGISTERED
New York District Office (NYK-DO)
5/11/2006
62WAR03ALUMINUM ACETATE (SOL) (ASTRINGENT/ANTI-PERSPIRANT)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
62MBJ08MENTHOL (ANTI-PRURITIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
62FAK08CHLORHEXIDINE HCL (ANTI-INFECTIVE, TOPICAL)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
62FBK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
60QCK67LIDOCAINE (ANESTHETIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
56ECO80TETRACYCLINE (TETRACYCLINES)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
61XCM13CYCLIZINE (ANTI-HISTAMINIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
61TCP12METOCLOPRAMIDE HCL (ANTI-EMETIC/NAUSEANT)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
56YCO99ANTIBIOTIC N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
65LBJ15ZINC OXIDE PASTE WITH SALICYLIC ACID (PROTECTANT)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
61HCA03TRIMETHOPRIM (ANTI-BACTERIAL)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
62GAA41IBUPROFEN (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
60LCA14CARBAMAZEPINE (ANALGESIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/11/2006
61KCP05ATROPINE SULFATE (ANTI-CHOLINERGIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
8/30/2005
79LRRKIT, FIRST AID
118NOT LISTED
341REGISTERED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Legaay International's FDA import refusal history?

Legaay International (FEI: 3004723151) has 23 FDA import refusal record(s) in our database, spanning from 8/30/2005 to 5/20/2014.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Legaay International's FEI number is 3004723151.

What types of violations has Legaay International received?

Legaay International has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Legaay International come from?

All FDA import refusal data for Legaay International is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.